glp-1 news today october 20 2025 Perspectives from employers on the costs and issues associated with covering agonists for weight loss Alarming rise in weight loss

Currently, tirzepatide is the most promising listed incretin analogue

(2021) found that GLP-1 could improve the cognition of mice by enhancing aerobic glycolysis and reducing the levels of oxidative phosphorylation and oxidative stress in the brain

I'm less interested in starting

Platforms like MeAgain's GLP-1 app address this problem by combining no-markup compounded medications with daily tracking tools that build consistency over months

Building muscle helps with the muscle loss from weight loss

A review of 63 trials involving more than 9,000 people, published in the British Medical Journal and cited by Global News , found that patients on weightloss drugs regained weight at an average of 0.4 kilograms per month after stopping treatment